Guangzhou Baiyunshan Pharmaceutical Holdings (00874) released its performance for the first three quarters, with a net profit attributable to shareholders of 3.31 billion yuan, an increase of 4.78% year-on-year.
Baiyunshan (00874) released its performance for the first three quarters of 2025, with the group's operating income reaching 61.606 billion yuan...
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) released its performance for the first three quarters of 2025. The group achieved operating income of 61.606 billion yuan, an increase of 4.31% year-on-year; net profit attributable to shareholders of the listed company was 3.31 billion yuan, an increase of 4.78% year-on-year; basic earnings per share were 2.036 yuan.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
